EzFill Holdings, Inc. Regains Compliance with NASDAQ Listing Standard
MIAMI, FL, Sept. 03, 2024 (GLOBE NEWSWIRE) — EzFill Holdings, Inc. (“EzFill”) or the “Company”) (NASDAQ: EZFL), a pioneer and […]
RecycLiCo Battery Materials Welcomes Maryam Rasouli, Ph.D. as Principal Engineer
SURREY, British Columbia, Sept. 03, 2024 (GLOBE NEWSWIRE) — RecycLiCo Battery Materials Inc. (“RecycLiCo” or the “Company”), (TSX.V: AMY | […]
Constellation Brands Updates Fiscal 2025 Outlook
Updates reported EPS guidance to $3.05 – $7.92 and raises lower-end of comparable EPS guidance to $13.60 – $13.80, affirming double-digit […]
Ghislain Houle, vice-président exécutif et chef de la direction financière prendra la parole dans le cadre de la 12e conférence annuelle de Laguna de Morgan Stanley le 11 septembre
MONTRÉAL, 03 sept. 2024 (GLOBE NEWSWIRE) — Ghislain Houle, vice-président exécutif et chef de la direction financière du CN (TSX : […]
Ghislain Houle, Executive Vice-President and Chief Financial Officer to Address Morgan Stanley’s 12th Annual Laguna Conference on September 11
MONTREAL, Sept. 03, 2024 (GLOBE NEWSWIRE) — Ghislain Houle, Executive Vice-President and Chief Financial Officer of CN (TSX: CNR) (NYSE: […]
Chromocell to Present at the H.C. Wainwright 26th Annual Global Investment Conference
FREEHOLD, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) — Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer […]
Apollo to Present at Barclays 22nd Annual Global Financial Services Conference
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Scott Kleinman, Co-President of Apollo Asset […]
Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society’s HRX Congress
ST. LOUIS, Sept. 03, 2024 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for […]
TSX News -
G2 Expands New Gold Zones at OKO – 57.5m @ 4.3 g/t Au, 38.2m @ 3.4 g/t Au & 69.5m @ 1.9 g/t Au
TORONTO, Sept. 03, 2024 (GLOBE NEWSWIRE) — G2 Goldfields Inc. (“G2” or the “Company”) (TSX: GTWO; OTCQX: GUYGF) is pleased […]
Outlook Therapeutics® to Present at the H.C. Wainwright 26th Annual Global Investment Conference
ISELIN, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval […]
